世界の急性心不全（AHF）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Acute Heart Failure (AHF) Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0056 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、急性心不全（AHF）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他）、用途別市場規模（病院、クリニック、在宅医療）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性心不全（AHF）治療の市場動向 ・企業の競争状況、市場シェア ・急性心不全（AHF）治療の種類別市場規模（B遮断薬、カルシウムチャネル遮断薬、強心配糖体、利尿薬、モルヒネ、血管拡張薬/硝酸塩、その他） ・急性心不全（AHF）治療の用途別市場規模（病院、クリニック、在宅医療） ・急性心不全（AHF）治療の北米市場規模2016-2027（アメリカ、カナダ） ・急性心不全（AHF）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性心不全（AHF）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性心不全（AHF）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性心不全（AHF）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer AG、Bristol-Myers Squibb Company、Cardiorentis AG、CVie Therapeutics Limited、Cytokinetics, Inc.、Merck & Co.、Novartis AG、Orion Corporation、PhaseBio Pharmaceuticals, Inc） ・結論

Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market
The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 1398 million by 2026, from US$ 262.2 million in 2019, at a CAGR of 26.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Heart Failure (AHF) Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Heart Failure (AHF) Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Heart Failure (AHF) Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Heart Failure (AHF) Therapeutics market.

Global Acute Heart Failure (AHF) Therapeutics Scope and Market Size
Acute Heart Failure (AHF) Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Heart Failure (AHF) Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
B-Blockers
Calcium Channel Blockers
Cardiac Glycosides
Diuretics
Morphine
Vasodilators/Nitrates
Others

Segment by Application
Hospital
Clinic
Home Care

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bayer AG
Bristol-Myers Squibb Company
Cardiorentis AG
CVie Therapeutics Limited
Cytokinetics, Inc.
Merck & Co.
Novartis AG
Orion Corporation
PhaseBio Pharmaceuticals, Inc

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 B-Blockers
1.2.3 Calcium Channel Blockers
1.2.4 Cardiac Glycosides
1.2.5 Diuretics
1.2.6 Morphine
1.2.7 Vasodilators/Nitrates
1.2.8 Others
1.3 Market by Application
1.3.1 Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Heart Failure (AHF) Therapeutics Market Perspective (2016-2027)
2.2 Acute Heart Failure (AHF) Therapeutics Growth Trends by Regions
2.2.1 Acute Heart Failure (AHF) Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Heart Failure (AHF) Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Heart Failure (AHF) Therapeutics Industry Dynamic
2.3.1 Acute Heart Failure (AHF) Therapeutics Market Trends
2.3.2 Acute Heart Failure (AHF) Therapeutics Market Drivers
2.3.3 Acute Heart Failure (AHF) Therapeutics Market Challenges
2.3.4 Acute Heart Failure (AHF) Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue
3.1.1 Global Top Acute Heart Failure (AHF) Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Heart Failure (AHF) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Heart Failure (AHF) Therapeutics Revenue
3.4 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio
3.4.1 Global Acute Heart Failure (AHF) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Heart Failure (AHF) Therapeutics Revenue in 2020
3.5 Acute Heart Failure (AHF) Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Heart Failure (AHF) Therapeutics Breakdown Data by Type
4.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2022-2027)

5 Acute Heart Failure (AHF) Therapeutics Breakdown Data by Application
5.1 Global Acute Heart Failure (AHF) Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
6.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type
6.2.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application
6.3.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country
6.4.1 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
7.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type
7.2.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application
7.3.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country
7.4.1 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type
9.2.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application
9.3.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country
9.4.1 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Acute Heart Failure (AHF) Therapeutics Introduction
11.1.4 Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.1.5 Bayer AG Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Cardiorentis AG
11.3.1 Cardiorentis AG Company Details
11.3.2 Cardiorentis AG Business Overview
11.3.3 Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Introduction
11.3.4 Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.3.5 Cardiorentis AG Recent Development
11.4 CVie Therapeutics Limited
11.4.1 CVie Therapeutics Limited Company Details
11.4.2 CVie Therapeutics Limited Business Overview
11.4.3 CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Introduction
11.4.4 CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.4.5 CVie Therapeutics Limited Recent Development
11.5 Cytokinetics, Inc.
11.5.1 Cytokinetics, Inc. Company Details
11.5.2 Cytokinetics, Inc. Business Overview
11.5.3 Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Introduction
11.5.4 Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.5.5 Cytokinetics, Inc. Recent Development
11.6 Merck & Co.
11.6.1 Merck & Co. Company Details
11.6.2 Merck & Co. Business Overview
11.6.3 Merck & Co. Acute Heart Failure (AHF) Therapeutics Introduction
11.6.4 Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.6.5 Merck & Co. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Acute Heart Failure (AHF) Therapeutics Introduction
11.7.4 Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Orion Corporation
11.8.1 Orion Corporation Company Details
11.8.2 Orion Corporation Business Overview
11.8.3 Orion Corporation Acute Heart Failure (AHF) Therapeutics Introduction
11.8.4 Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.8.5 Orion Corporation Recent Development
11.9 PhaseBio Pharmaceuticals, Inc
11.9.1 PhaseBio Pharmaceuticals, Inc Company Details
11.9.2 PhaseBio Pharmaceuticals, Inc Business Overview
11.9.3 PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Introduction
11.9.4 PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
11.9.5 PhaseBio Pharmaceuticals, Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of B-Blockers
Table 3. Key Players of Calcium Channel Blockers
Table 4. Key Players of Cardiac Glycosides
Table 5. Key Players of Diuretics
Table 6. Key Players of Morphine
Table 7. Key Players of Vasodilators/Nitrates
Table 8. Key Players of Others
Table 9. Global Acute Heart Failure (AHF) Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Acute Heart Failure (AHF) Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2016-2021)
Table 13. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2022-2027)
Table 15. Acute Heart Failure (AHF) Therapeutics Market Trends
Table 16. Acute Heart Failure (AHF) Therapeutics Market Drivers
Table 17. Acute Heart Failure (AHF) Therapeutics Market Challenges
Table 18. Acute Heart Failure (AHF) Therapeutics Market Restraints
Table 19. Global Acute Heart Failure (AHF) Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players (2016-2021)
Table 21. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2020)
Table 22. Ranking of Global Top Acute Heart Failure (AHF) Therapeutics Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Acute Heart Failure (AHF) Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Acute Heart Failure (AHF) Therapeutics Product Solution and Service
Table 26. Date of Enter into Acute Heart Failure (AHF) Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2016-2021)
Table 30. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Acute Heart Failure (AHF) Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application (2016-2021)
Table 34. Global Acute Heart Failure (AHF) Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 66. Bayer AG Company Details
Table 67. Bayer AG Business Overview
Table 68. Bayer AG Acute Heart Failure (AHF) Therapeutics Product
Table 69. Bayer AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Bayer AG Recent Development
Table 71. Bristol-Myers Squibb Company Company Details
Table 72. Bristol-Myers Squibb Company Business Overview
Table 73. Bristol-Myers Squibb Company Acute Heart Failure (AHF) Therapeutics Product
Table 74. Bristol-Myers Squibb Company Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Bristol-Myers Squibb Company Recent Development
Table 76. Cardiorentis AG Company Details
Table 77. Cardiorentis AG Business Overview
Table 78. Cardiorentis AG Acute Heart Failure (AHF) Therapeutics Product
Table 79. Cardiorentis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Cardiorentis AG Recent Development
Table 81. CVie Therapeutics Limited Company Details
Table 82. CVie Therapeutics Limited Business Overview
Table 83. CVie Therapeutics Limited Acute Heart Failure (AHF) Therapeutics Product
Table 84. CVie Therapeutics Limited Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 85. CVie Therapeutics Limited Recent Development
Table 86. Cytokinetics, Inc. Company Details
Table 87. Cytokinetics, Inc. Business Overview
Table 88. Cytokinetics, Inc. Acute Heart Failure (AHF) Therapeutics Product
Table 89. Cytokinetics, Inc. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Cytokinetics, Inc. Recent Development
Table 91. Merck & Co. Company Details
Table 92. Merck & Co. Business Overview
Table 93. Merck & Co. Acute Heart Failure (AHF) Therapeutics Product
Table 94. Merck & Co. Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck & Co. Recent Development
Table 96. Novartis AG Company Details
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Acute Heart Failure (AHF) Therapeutics Product
Table 99. Novartis AG Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Novartis AG Recent Development
Table 101. Orion Corporation Company Details
Table 102. Orion Corporation Business Overview
Table 103. Orion Corporation Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Orion Corporation Recent Development
Table 105. PhaseBio Pharmaceuticals, Inc Company Details
Table 106. PhaseBio Pharmaceuticals, Inc Business Overview
Table 107. PhaseBio Pharmaceuticals, Inc Acute Heart Failure (AHF) Therapeutics Product
Table 108. PhaseBio Pharmaceuticals, Inc Revenue in Acute Heart Failure (AHF) Therapeutics Business (2016-2021) & (US$ Million)
Table 109. PhaseBio Pharmaceuticals, Inc Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Heart Failure (AHF) Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. B-Blockers Features
Figure 3. Calcium Channel Blockers Features
Figure 4. Cardiac Glycosides Features
Figure 5. Diuretics Features
Figure 6. Morphine Features
Figure 7. Vasodilators/Nitrates Features
Figure 8. Others Features
Figure 9. Global Acute Heart Failure (AHF) Therapeutics Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Home Care Case Studies
Figure 13. Acute Heart Failure (AHF) Therapeutics Report Years Considered
Figure 14. Global Acute Heart Failure (AHF) Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Acute Heart Failure (AHF) Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions: 2020 VS 2027
Figure 17. Global Acute Heart Failure (AHF) Therapeutics Market Share by Regions (2022-2027)
Figure 18. Global Acute Heart Failure (AHF) Therapeutics Market Share by Players in 2020
Figure 19. Global Top Acute Heart Failure (AHF) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Heart Failure (AHF) Therapeutics as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Acute Heart Failure (AHF) Therapeutics Revenue in 2020
Figure 21. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2016-2021)
Figure 22. Global Acute Heart Failure (AHF) Therapeutics Revenue Market Share by Type (2022-2027)
Figure 23. North America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 25. North America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 26. North America Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 27. United States Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 31. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 32. Europe Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 33. Germany Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Acute Heart Failure (AHF) Therapeutics Market Share by Region (2016-2027)
Figure 43. China Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 51. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 52. Latin America Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 53. Mexico Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Acute Heart Failure (AHF) Therapeutics Market Share by Country (2016-2027)
Figure 59. Turkey Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Acute Heart Failure (AHF) Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Company Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 64. Cardiorentis AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 65. CVie Therapeutics Limited Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 66. Cytokinetics, Inc. Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 67. Merck & Co. Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 68. Novartis AG Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 69. Orion Corporation Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 70. PhaseBio Pharmaceuticals, Inc Revenue Growth Rate in Acute Heart Failure (AHF) Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---